SARS-CoV-2 Omicron infection augments the magnitude and durability of systemic and mucosal immunity in triple-dose CoronaVac recipients.
Yuxin ChenTiantian ZhaoLin ChenGuozhi JiangYu GengWanting LiShengxia YinXin TongYue TaoJun NiQiuhan LuMingzhe NingChao WuPublished in: mBio (2024)
This study is registered with ClinicalTrials.gov as NCT05680896.